Loading insider details...
Latest Form 4 (Sep 21, 2026): Grant/Award of 12,200 GRCE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | Grace Therapeutics, Inc. (GRCE) | Grant/Award | 12,200 | n/a |
| Jan 12, 2026 | Grace Therapeutics, Inc. (GRCE) | Grant/Award | 10,000 | n/a |
| May 13, 2025 | Grace Therapeutics, Inc. (GRCE) | Grant/Award | 10,000 | n/a |
| Dec 20, 2023 | Acasti Pharma Inc. (ACST) | Grant/Award | 22,500 | n/a |
| Jun 23, 2022 | Acasti Pharma Inc. (ACST) | Grant/Award | 50,000 | n/a |